Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 390, pseudogene (RN7SL390P) is a human pseudogene derived from the 7SL RNA, which is the RNA component of the signal recognition particle (SRP)[6][1][8]. The functional 7SL RNA is a non-coding RNA that is part of the SRP complex, central to targeting secretory proteins to the endoplasmic reticulum membrane in eukaryotic cells[5][7]. RN7SL390P, however, is non-functional; it does not code for a functional RNA molecule or protein. The majority of 7SL-related sequences in the human genome are pseudogenes generated by the retrotransposition of 7SL RNA, resulting in truncated, non-expressed loci dispersed throughout the genome[8]. There is no evidence that RN7SL390P has a biological function, disease association, or drug interactions. It is not considered a therapeutic target or a functional molecular entity[6][1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 390, pseudogene (RN7SL390P).